Domenica De Santis

Domenica De Santis

Auto-generated profile, based on publicly available information

Domenica De Santis

Department of Medicine, University of Verona School of Medicine, Verona, Italy

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Molecular Aspects of Medicine
Verified
Journal Article
Closed access
SFSimonetta Friso
Simonetta Friso
SUSilvia Udali
Silvia Udali
DSDomenica De Santis
Domenica De Santis
SCSang-Woon Choi
Sang-Woon Choi

13 December 2017 in European Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
SUSilvia Udali
Silvia Udali
ACAnnalisa Castagna
Annalisa Castagna
MCMichela Corbella
Michela Corbella
ARAndrea Ruzzenente
Andrea Ruzzenente
SMSara Moruzzi
Sara Moruzzi
SFSimonetta Friso
Simonetta Friso

9 January 2018 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
SUSilvia Udali
Silvia Udali
DSDomenica De Santis
Domenica De Santis
ARAndrea Ruzzenente
Andrea Ruzzenente
SMSara Moruzzi
Sara Moruzzi
FMFilippo Mazzi
Filippo Mazzi
SFSimonetta Friso
Simonetta Friso
Colon cancer is one of the most frequent solid tumor and simultaneous diagnosis of primary colon cancer and liver metastases occurs in about one fourth of cases. The current knowledge on epigenetic signatures, especially those related to hydroxymethylation in primary cancer tissue, synchronous metastasis, and blood circulating cells is lacking. This study aimed to investigate both methylcytosine (mCyt) and hydroxymethylcytosine (hmCyt) status in the DNA of individual patients from colon cancer tissue, synchronous liver metastases, and in cancer-free colon and liver tissues and leukocytes. Patients undergoing curative surgery (n = 16) were enrolled and their laboratory and clinical history data collected. The contents of mCyt and hmCyt were determined by a liquid chromatography/mass spectrometry (LC/MS/MS) method in DNA extracted from primary colon cancer, synchronous hepatic metastatic tissues and homologous cancer-free tissues, i.e., colon and liver tissues as well as leukocytes. The mCyt and hmCyt levels were compared between cancerous and cancer-free tissues, and correlations between leukocytes and colon/liver tissues for both the mCyt and hmCyt levels were evaluated. The mCyt levels were similar in primary colon cancer and liver metastasis tissues (4.69 ± 0.37% vs. 4.77 ± 0.38%, respectively, p = 0.535), and both primary and metastatic tissues were hypomethylated compared to cancer-free colon (4.98 ± 0.26%). The difference in the mCyt content between cancerous and cancer-free colon tissues was significantly lower in primary colon cancer (p = 0.004), but not in liver metastasis (p = 0.148). The hmCyt content was similar in primary colon cancer compared to liver metastasis (0.035%, C.I. 0.024–0.052% versus 0.035%, C.I. 0.021–0.058%, respectively, p = 0.905) and markedly depleted compared to the cancer-free colon (0.081%, C.I. 0.055–0.119%) with a statistically significant difference (p < 0.05) for both comparisons. The mCyt levels showed a borderline correlation between leukocytes and colon cancer tissue (Pearson’s correlation coefficient = 0.51, p = 0.052) while no correlations were detected for the hmCyt levels. In conclusion, primary colon cancer and synchronous liver metastasis tissues showed a similar epigenetic status but were significantly hypomethylated and hypohydroxymethylated as compared to homologous cancer-free colon tissues.

17 August 2022 in Journal of Human Hypertension
Verified
Journal Article
Closed access
PDF file
FPFrancesca Pizzolo
Francesca Pizzolo
LBLorenzo Bertolone
Lorenzo Bertolone
ACAnnalisa Castagna
Annalisa Castagna
FMFrancesca Morandini
Francesca Morandini
GSGiulia Sartori
Giulia Sartori
OOOliviero Olivieri
Oliviero Olivieri